Victor Jimenez-Zepeda

10PUBLICATIONS
17CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 18, 2025
Clinical outcomes and healthcare resource use in triple-class exposed patients with relapsed/refractory multiple myeloma.

Victor H Jimenez-Zepeda, Winson Y Cheung, Mariet Mathew Stephen

|Aug 27, 2025
BCMA CAR-T: From Multiple Myeloma to Light-Chain Amyloidosis.

Ellen Lewis, Victor Hugo Jimenez-Zepeda

|Dec 27, 2024
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review.

Jessie Luo, Nizar J Bahlis, Denise Chan

|Sep 27, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of Calgary.

Ellen Lewis, Nowell Fine, Sylvia McCulloch

|Jun 19, 2024
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database.

Rayan Kaedbey, Donna Reece, Christopher P Venner

|Aug 13, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.

Richard LeBlanc, Hira Mian, Donna Reece

Pageof 2

Frequent Collaborators

3 joint publications

Esther Masih-Khan

2 joint publications

Hannah M Cherniawsky

2 joint publications

Hira Mian

2 joint publications

Antony Reiman